Aka iceman_ex. Husband, Intensivist, Ultrascoundrel. @ics-updates.bsky.social. All about the #medsky, #foamed and #foamcc. Meme: papers ratio over 9000
Segun Olusanya (He/Him)
Loading...
#CCR26 #VICTORYtrial published now in @jama.com, with Chris Seymour (Associate Editor for Critical Care, JAMA) chairing this session in Belfast!
https://t.co/ximnEAoJMm
📊 Research Summary: High-dose intravenous #VitaminC did not improve mortality or organ function in adults with severe burns and may increase risk of adverse outcomes, supporting the removal of vitamin C from acute burn protocols.
#CCR26 @criticalcarereviews.com
ja.ma/4v31fkv
So is it finally dead yet, or do we need precision medicine to identify vitamin C responders?
(This is sarcasm)
💬 Editorial: High-dose intravenous #VitaminC did not reduce organ dysfunction or mortality in patients with large burns and may increase mortality, supporting its removal from standard burn resuscitation protocols.
#CCR26 @criticalcarereviews.com
ja.ma/4xiBIFp
Wow! MARCH trial results show no significant benefit for hypertonic saline and carbocisteine in ventilated ICU patients, and significant harm associated with both. Very well done to all of the investigators!
www.nejm.org/doi/full/10....
#CCR26
🤔
The panel discussing VICTORY trial do feel that there should be a moratorium on Vit C trials. I'm pretty sure this will not be heeded. #CCR26
Maybe we need more trials 🤔
🏥 Ross Davenport, CX Vascular trauma board member, joins Vascular News to discuss how the first-ever @esvs-vascular.bsky.social clinical practice guidelines on the management of vascular trauma are helping reshape practice.
vascularnews.com/how-european...
This is data from a different UK institution from 2018. Numbers are similar.
www.bjanaesthesia.org.uk/article/S000...
Segun Olusanya (He/Him)
JAMA
Mucoactive agents are widely used in patients with acute respiratory failure despite
limited evidence of their effectiveness or safety. We conducted a multicenter, open-label,
randomized trial with...
